GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Pretax Margin %

Panacea Biotec (BOM:531349) Pretax Margin % : 2.68% (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Panacea Biotec's Pre-Tax Income for the three months ended in Dec. 2024 was ₹44 Mil. Panacea Biotec's Revenue for the three months ended in Dec. 2024 was ₹1,635 Mil. Therefore, Panacea Biotec's pretax margin for the quarter that ended in Dec. 2024 was 2.68%.

The historical rank and industry rank for Panacea Biotec's Pretax Margin % or its related term are showing as below:

BOM:531349' s Pretax Margin % Range Over the Past 10 Years
Min: -31.87   Med: -6.39   Max: 219.86
Current: -1.81


BOM:531349's Pretax Margin % is ranked better than
72.46% of 995 companies
in the Biotechnology industry
Industry Median: -125.57 vs BOM:531349: -1.81

Panacea Biotec Pretax Margin % Historical Data

The historical data trend for Panacea Biotec's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Pretax Margin % Chart

Panacea Biotec Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.87 -23.35 219.86 2.80 0.27

Panacea Biotec Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.10 -1.64 -14.73 3.23 2.68

Competitive Comparison of Panacea Biotec's Pretax Margin %

For the Biotechnology subindustry, Panacea Biotec's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Biotec's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's Pretax Margin % falls into.


;
;

Panacea Biotec Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Panacea Biotec's Pretax Margin for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=14.77/5519.29
=0.27 %

Panacea Biotec's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=43.8/1634.9
=2.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacea Biotec  (BOM:531349) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Panacea Biotec Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec Business Description

Traded in Other Exchanges
Address
Mathura Road, B-1 Extension/G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec Headlines

No Headlines